Cargando…
Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
BACKGROUND: Respiratory syncytial virus (RSV) is the number one cause of lower respiratory tract infections in infants. There are still no vaccines or specific antiviral therapies against RSV, mainly due to the inadequate understanding of RSV pathogenesis. Recent data suggest a role for gut microbio...
Autores principales: | Harding, Jeffrey N., Siefker, David, Vu, Luan, You, Dahui, DeVincenzo, John, Pierre, JF., Cormier, Stephania A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268675/ https://www.ncbi.nlm.nih.gov/pubmed/32487019 http://dx.doi.org/10.1186/s12866-020-01816-5 |
Ejemplares similares
-
Building a better neonatal mouse model to understand infant respiratory syncytial virus disease
por: You, Dahui, et al.
Publicado: (2015) -
Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33
por: Saravia, Jordy, et al.
Publicado: (2015) -
Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy
por: Hijano, Diego R., et al.
Publicado: (2018) -
Impaired gamma delta T cell-derived IL-17A and inflammasome activation during early respiratory syncytial virus infection in infants
por: Huang, Huaqiong, et al.
Publicado: (2014) -
A role for airway remodeling during respiratory syncytial virus infection
por: Becnel, David, et al.
Publicado: (2005)